Peer-reviewed veterinary case report
Placebo works as well as antibiotics after dog pyometra surgery
By Ylhäinen, Anna et al.·Published in Veterinary journal (London, England : 1997)·2025·Department of Equine and Small Animal Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Placebo is non-inferior to postoperative antimicrobial treatment in uncomplicated canine pyometra - A double-blinded randomized controlled trial.
- Species:
- dog
Plain-English summary
A group of dogs that had surgery for pyometra (a serious uterine infection) were given either a placebo or a five-day course of antibiotics to see if the antibiotics were really necessary. The study found that the dogs who received the placebo had a lower rate of surgical site infections compared to those who received the antibiotics. This suggests that just one dose of antibiotics before surgery may be enough to prevent infections in uncomplicated cases. As a result, many dogs may not need additional antibiotics after surgery, which could help reduce antibiotic resistance.
People also search for: dog pyometra surgery recovery · antibiotics after dog surgery · canine pyometra treatment options
Abstract
Postoperative antimicrobial therapy is frequently administered after surgical treatment for pyometra in dogs, despite limited evidence supporting its necessity in uncomplicated cases. Antimicrobial resistance concerns call for re-evaluation of such practices. This randomized, double-blinded, placebo-controlled, non-inferiority clinical trial was conducted on client-owned dogs at the Veterinary Teaching Hospital of the University of Helsinki. All dogs received perioperative sulfadoxine-trimethoprim prophylaxis and were then randomized to receive either placebo or a five-day course of oral sulfadiazine-trimethoprim as active control. The primary outcome was the incidence of surgical site infections (SSI) within 30 days; the secondary outcome was the incidence of clinical urinary tract infections (UTI) within 12 days. The non-inferiority margins were set at 7 % (SSI) and 15 % (UTI). Infection outcomes were assessed in both the intention-to-treat (ITT) and per-protocol populations (PP). A total of 152 dogs were included. In the ITT population, SSI incidence was 2.7 % in the placebo group and 7.8 % in the sulfadiazine-trimethoprim group, with an absolute difference of -5.1 % (CI: -13.6-2.8 %). UTI incidence was 0 % in the placebo group and 3.9 % in the sulfadiazine-trimethoprim group (difference -7.7 %, CI: -24.1-8.2 %). Results in the PP were similar. All findings supported the non-inferiority of placebo. A single perioperative dose of sulfadoxine-trimethoprim appears sufficient for preventing postoperative infections in this low-risk surgical population.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40998150/